Article Text

PDF
Non-cystic fibrosis bronchiectasis: its diagnosis and management
  1. Patrick Stafler,
  2. Siobhán B Carr
  1. Paediatric Respiratory Unit, Barts and The London Children's Hospital, London, UK
  1. Correspondence to Dr Siobhán Carr, Paediatric Respiratory Unit, Barts and The London Children's Hospital, 2nd Floor Fielden House, Whitechapel, London E1 1BB, UK; siobhan.carr{at}bartsandthelondon.nhs.uk

Abstract

An increase in the frequency of diagnosing non-cystic fibrosis bronchiectasis in children is due to heightened awareness of the disease and the wider availability of high-resolution computed tomography. The most common underlying conditions leading to bronchiectasis include infections, immunodeficiency, aspiration and primary ciliary dyskinesia. Treatment centres on airway clearance with aggressive antibiotic regimens and physiotherapy; more specific approaches are available for some of the underlying conditions. A high index of suspicion that a child may have underlying bronchiectasis must be maintained in the presence of prolonged or recurrent “wet/productive” cough. The classic definition of bronchiectasis is of irreversible bronchial dilatation; however, at the milder end of the spectrum it appears that radiographic changes may be reversible. Untreated, in its severest form bronchiectasis can progress to end stage pulmonary failure in adult life. In this article, we review its pathogenesis and diagnosis and the evidence base for available treatments.

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.